ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 543 filers reported holding ASTRAZENECA PLC in Q3 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,241 | -11.4% | 3,695 | -6.3% | 0.06% | -10.4% |
| Q2 2023 | $282,360 | +20.5% | 3,945 | +16.9% | 0.07% | +15.5% |
| Q1 2023 | $234,344 | -6.0% | 3,376 | -8.2% | 0.06% | -31.8% |
| Q4 2022 | $249,248 | +21.0% | 3,676 | -2.3% | 0.08% | +21.4% |
| Q3 2022 | $206,000 | -16.9% | 3,762 | +0.1% | 0.07% | -15.7% |
| Q2 2022 | $248,000 | -0.4% | 3,759 | 0.0% | 0.08% | +20.3% |
| Q1 2022 | $249,000 | +14.2% | 3,759 | +0.1% | 0.07% | +13.1% |
| Q4 2021 | $218,000 | -3.1% | 3,755 | 0.0% | 0.06% | -10.3% |
| Q3 2021 | $225,000 | +11.9% | 3,755 | +11.6% | 0.07% | +13.3% |
| Q2 2021 | $201,000 | +20.4% | 3,366 | 0.0% | 0.06% | +15.4% |
| Q1 2021 | $167,000 | -16.1% | 3,366 | -15.8% | 0.05% | -20.0% |
| Q4 2020 | $199,000 | -21.3% | 3,998 | -13.5% | 0.06% | -30.9% |
| Q3 2020 | $253,000 | +3.7% | 4,622 | +0.0% | 0.09% | +5.6% |
| Q2 2020 | $244,000 | +63.8% | 4,621 | +37.6% | 0.09% | +50.8% |
| Q1 2020 | $149,000 | -11.8% | 3,358 | +0.1% | 0.06% | +5.4% |
| Q4 2019 | $169,000 | +13.4% | 3,356 | 0.0% | 0.06% | +5.7% |
| Q3 2019 | $149,000 | +8.0% | 3,356 | +0.1% | 0.05% | +6.0% |
| Q2 2019 | $138,000 | -36.1% | 3,354 | -37.4% | 0.05% | -35.9% |
| Q1 2019 | $216,000 | +2.4% | 5,354 | -4.3% | 0.08% | -11.4% |
| Q4 2018 | $211,000 | -12.4% | 5,597 | -8.2% | 0.09% | -5.4% |
| Q3 2018 | $241,000 | +13.1% | 6,095 | +0.0% | 0.09% | +9.4% |
| Q2 2018 | $213,000 | 0.0% | 6,092 | 0.0% | 0.08% | -3.4% |
| Q1 2018 | $213,000 | -8.6% | 6,092 | -9.3% | 0.09% | -13.7% |
| Q4 2017 | $233,000 | +2.6% | 6,715 | 0.0% | 0.10% | -3.8% |
| Q3 2017 | $227,000 | -1.3% | 6,715 | -0.9% | 0.11% | -10.9% |
| Q2 2017 | $230,000 | +9.5% | 6,773 | 0.0% | 0.12% | +6.2% |
| Q1 2017 | $210,000 | +14.1% | 6,773 | +0.4% | 0.11% | +7.7% |
| Q4 2016 | $184,000 | -23.3% | 6,746 | -7.9% | 0.10% | -23.5% |
| Q3 2016 | $240,000 | -2.0% | 7,326 | -10.0% | 0.14% | +1.5% |
| Q2 2016 | $245,000 | +44.1% | 8,142 | +34.7% | 0.13% | +42.6% |
| Q1 2016 | $170,000 | -16.7% | 6,044 | +0.4% | 0.09% | +3.3% |
| Q4 2015 | $204,000 | +6.8% | 6,022 | 0.0% | 0.09% | +1.1% |
| Q3 2015 | $191,000 | 0.0% | 6,022 | +100.0% | 0.09% | +3.4% |
| Q2 2015 | $191,000 | -7.3% | 3,011 | 0.0% | 0.09% | -4.4% |
| Q1 2015 | $206,000 | -2.8% | 3,011 | 0.0% | 0.09% | -7.1% |
| Q4 2014 | $212,000 | -14.9% | 3,011 | -13.6% | 0.10% | -36.4% |
| Q3 2014 | $249,000 | -18.9% | 3,486 | -15.7% | 0.15% | -56.0% |
| Q2 2014 | $307,000 | -39.0% | 4,136 | -46.6% | 0.35% | -16.3% |
| Q1 2014 | $503,000 | +2.0% | 7,750 | -6.6% | 0.42% | 0.0% |
| Q4 2013 | $493,000 | +15.7% | 8,300 | +1.2% | 0.42% | +1.2% |
| Q3 2013 | $426,000 | +21.4% | 8,200 | +10.4% | 0.41% | -20.0% |
| Q2 2013 | $351,000 | – | 7,425 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |